CIK 0001006028 · Non-accelerated filer<br>Smaller reporting company
PURE BIOSCIENCE, INC.
Sign in to watch- Ticker
- PURE
- Exchange
- OTC
- Industry
- Miscellaneous Chemical Products
- FY end
- Jul 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330530289
- Phone
- 619-596-8600
- Business address
- 771 JAMACHA ROAD #512, EL CAJON, CA, 92019
- Former names
- PURE BIOSCIENCE, INNOVATIVE MEDICAL SERVICES
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-20 | Myers Thomas Richard Exec VP, Tech & Development | Grant or award · Stock Option (Right to Buy) | +155,000 | 155,000 | ||
| 2024-08-20 | Rendall David Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2024-08-20 | Blotner Bernard Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2024-08-20 | Elliott Mark Stuart Vice President, Finance | Grant or award · Stock Option (Right to Buy) | +155,000 | 155,000 | ||
| 2024-08-20 | Lee Tom Y Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2024-08-20 | BARTLETT ROBERT F CEO and President | Grant or award · Stock Option (Right to Buy) | +155,000 | 155,000 | ||
| 2024-08-20 | BARTLETT ROBERT F CEO and President | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2024-08-20 | Chen Ivan Director | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2024-08-20 | Zehr Darin Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2023-08-01 | Rendall David Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2023-08-01 | Myers Thomas Richard Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2023-08-01 | Lee Tom Y Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2023-08-01 | Elliott Mark Stuart Vice President, Finance | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2023-08-01 | Chen Ivan Director | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2023-08-01 | Blotner Bernard Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2023-08-01 | BARTLETT ROBERT F CEO | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2023-03-22 | BARTLETT ROBERT F CEO | Purchase | +50,000 | $0.16 | $8K | 50,000 |
| 2023-03-21 | Blotner Bernard Director | Purchase | +10,000 | $0.13 | $1K | 10,000 |
| 2022-12-15 | Lee Tom Y Chief Executive Officer | Purchase | +50,000 | $0.13 | $7K | 5,001,843 |
| 2022-09-30 | Elliott Mark Stuart Vice President, Finance | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 |
Page 1 of 9 · 172 trades